Clinical study of low dose and low concentration ropivacaine nerve block in single-port thoracoscopic lobectomy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048084

Enrollment

Unknown

Registered

2021-06-30

Start date

2021-07-10

Completion date

Unknown

Last updated

2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Single-port thoracoscopic lobectomy

Interventions

Group A:intercostal nerve block

Group B:serratus anterior plane block

Eligibility

Sex/Gender

All

Age

40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing single- port thoracoscopic lobectomy in our hospity during July 2021 to June 2022; 2. Aged 40 to 75 years; 3. ASA I - III; 4. weight 40-90kg.

Exclusion criteria

Exclusion criteria: 1. Contraindications to regional block technique; 2. Alcohol or drug abuse; 3. Evidence of serious circulatory disease; 4. A prior history of chronic pain; 5. Difficulties in communication; 6. Active gastrointestinal ulcer or bleeding; 7. No informed consent was signed.

Design outcomes

Primary

Measure	Time frame
First press time of analgesia pump;Anesthesia time;	—

Secondary

Measure	Time frame
Pain scores of rest and movement;number of times of pressure of analgesia pump 24h and 48h after surgery;Postoperative Quality of Recovery Score ;The amount of remedial drugs used after surgery;Postoperative hospital stay;Postoperative adverse reactions;Dosage of anesthetics ?Dosage of vasoactive drugs and infusion quantity;Operation time;interoperative adverse events;Haemodynamics;	—

Countries

China

Contacts

Public ContactXu Guanghong

First Affiliated Hospital of Anhui Medical University

xuguanghong2004@163.com+86 13856949535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026